TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06017284

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide
Description: Thalidomide 100 mg/day, once a day, orally intake at night.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: nab-paclitaxel (120 mg per square meter of body-surface area) on days 1, 8, and 15 every 4 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: nab-paclitaxel (120 mg per square meter of body-surface area) on days 1, 8, and 15 every 4 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo, 100 mg/day, once a day, orally intake at night.
Study: NCT05148455

Intervention type: OTHER
Intervention: standard-of-care clinical skin examination
Description: inspection of melanocytic nevi by dermatologist

Intervention type: OTHER
Intervention: standard-of-care clinical skin examination
Description: inspection of melanocytic nevi by dermatologist

Intervention type: DIAGNOSTIC_TEST
Intervention: skin assessment with the 2D FotoFinder ATBM master system
Description: The FotoFinder® ATBM master device provides the combination of total body mapping with deep learning-driven body scan algorithm which identifies all pigmented skin lesions of the body surface by pattern recognition software and supplies a risk assessment score (0.0-1.0; 0 indicating no suspicion for melanoma, 1 indicating a high suspicion for melanoma).The integrated software analyzer scores regarding malignancy probability of the moles (FotoFinder® score: 0.0-1.0) will be collected.

Intervention type: DIAGNOSTIC_TEST
Intervention: skin assessment with the 2D FotoFinder ATBM master system
Description: The FotoFinder® ATBM master device provides the combination of total body mapping with deep learning-driven body scan algorithm which identifies all pigmented skin lesions of the body surface by pattern recognition software and supplies a risk assessment score (0.0-1.0; 0 indicating no suspicion for melanoma, 1 indicating a high suspicion for melanoma).The integrated software analyzer scores regarding malignancy probability of the moles (FotoFinder® score: 0.0-1.0) will be collected.

Intervention type: OTHER
Intervention: data collection by participant questionnaire
Description: At baseline, the participants will complete a questionnaire concerning their previous exposure to sun, their current sun-related protective behaviours, their history of skin check frequency and skin cancer at baseline. Additionally, in each consultation newly-created study-specific questions concerning the participants' examination experience, the sun-related protective behaviours and worries about skin cancer throughout the study will be investigated.
Study: NCT06535178

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Regularity Group
Description: Maintained consistent sleep onset time (±30 min self-selected sleep time) for 12-weeks.
Study: NCT05759091

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive defusion techniques
Description: Defusing from your delusions helps to lessen their negative impact on your behaviour. So defusion is a vital step towards being able to act flexibly, in accordance with core values, instead of being dictated to by inflexible rules, reasons, judgments etc. There are numerous exercises in ACT Companion with a focus on identifying unhelpful thoughts which would benefit from defusion, or building defusion skills, most of which are found in the open up section of the app. Some of these are reading and writing exercises, and some are guided meditation audio recordings.~ACT Companion defusion exercises~1. Letting go~2. Not good enough~3. Thought defusion~4. Observing your thoughts~5. Labelling thoughts and feelings~6. I am having the thought that.....~7. milk.milk.milk exercise~8. silly voice exercise, passenger on the bus, tug of war with a monster
Study: NCT06129058

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: At-home transcranial direct current stimulation (tDCS)
Description: 30 minutes session 5 days/week for 3 weeks.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham at-home tDCS
Description: 30 minutes session 5 days/week for 3 weeks.
Study: NCT06071000

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuro-developmental stimulation (Neuro-vývojová stimulace).
Description: Neuro-developmental stimulation is exercise based intervention program that is focused on repeating reflex movements and thus inhibiting reflexive response.
Study: NCT05233891

Intervention type: PROCEDURE
Intervention: Breast reconstruction
Description: Breast reconstruction after breast cancer.

Intervention type: PROCEDURE
Intervention: Breast reduction
Description: Breast reduction due to breast hypertrophy.
Study: NCT05163860

Intervention type: OTHER
Intervention: Survey
Description: Participants will complete an online survey.

Intervention type: OTHER
Intervention: Survey
Description: Participants will complete an online survey.
Study: NCT05148455

Intervention type: OTHER
Intervention: data collection by participant questionnaire
Description: At baseline, the participants will complete a questionnaire concerning their previous exposure to sun, their current sun-related protective behaviours, their history of skin check frequency and skin cancer at baseline. Additionally, in each consultation newly-created study-specific questions concerning the participants' examination experience, the sun-related protective behaviours and worries about skin cancer throughout the study will be investigated.
Study: NCT05862714

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluconazole
Description: 400 mg stat. Follow up at 4 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluconazole
Description: 400 mg stat. Follow up at 4 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itraconazole
Description: 1000 mg stat. Follow up at 4 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itraconazole
Description: 1000 mg stat. Follow up at 4 weeks
Study: NCT05163860

Intervention type: OTHER
Intervention: Survey
Description: Participants will complete an online survey.
Study: NCT06536296

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: Arm 1: Music only

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music and parent voice
Description: Arm 2: Music and parent voice

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Standard Care
Study: NCT05413538

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Description: The intervention recordings will teach the basic concepts of mindfulness through simple guided meditations with content supported by science. Each recording has the same format that included (1) a daily theme, (2) a meditation exercise echoing the theme, (3) a suggested exercise for practice, and (4) an invitation for participants to give a short response to their meditation experience at the end of the recording.
Study: NCT02503280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous hMSCs
Description: Autologous hMSCs: 40 million cells/ml delivered in 0.5 ml injection volumes times 10 injections for a total of 2 x 10\^8 (200 million) hMSCs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous Human C-Kit CSCs II
Description: Autologous hMSCs PLUS autologous C-Kit hCSCs: Mixture of 39.8 million hMSCs and 0.2 million C-Kit hCSCs/ml delivered in 0.5 ml injection volumes times 10 injections for a total of 1.99 x 10\^8 (199 million) hMSCs and 1 million C-Kit hCSCs.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (ten 0.5 ml injections of phosphate-buffered saline \[PBS\] and 1% human serum albumin \[HSA\]).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biosense Webster MyoStar NOGA Injection Catheter System
Description: Biosense Webster MyoStar NOGA Injection Catheter System will be used to administer the study drug

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biosense Webster MyoStar NOGA Injection Catheter System
Description: Biosense Webster MyoStar NOGA Injection Catheter System will be used to administer the study drug

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Biosense Webster MyoStar NOGA Injection Catheter System
Description: Biosense Webster MyoStar NOGA Injection Catheter System will be used to administer the study drug
Study: NCT05052827

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Milk Protein Concentrate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 363 Carbs (g): 5.60 Protein (g): 82.60 Fat (g): 1.12 Total BCAA (g): 15.67 Total EAA (g): 34.66 Total AA (g): 83.27

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Milk Protein Concentrate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 363 Carbs (g): 5.60 Protein (g): 82.60 Fat (g): 1.12 Total BCAA (g): 15.67 Total EAA (g): 34.66 Total AA (g): 83.27

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Milk Protein Concentrate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 363 Carbs (g): 5.60 Protein (g): 82.60 Fat (g): 1.12 Total BCAA (g): 15.67 Total EAA (g): 34.66 Total AA (g): 83.27

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rice Protein Isolate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 394 Carbs (g): 6.50 Protein (g): 86.70 Fat (g): 2.39 Total BCAA (g): 14.98 Total EAA (g): 30.62 Total AA (g): 86.11
Study: NCT05331183

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ELX/TEZ/IVA
Description: Fixed-dose combination (FDC) tablets for oral administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVA
Description: Tablets for oral administration.
Study: NCT05036083

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Mammography
Description: Undergo CEM

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Digital Tomosynthesis Mammography
Description: Undergo DBT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Medical records reviewed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iodinated Contrast Agent
Description: Given IV
Study: NCT05787769

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: P shot arm ( Autologous Platelet Rich Plasma)
Description: Autologous Platelet Rich Plasma + placebo tab Each injection session will consist of a total of 10 mL PRP infused slowly over a 2-minute period; 5 mL each injected to the right and left corpus cavernosum

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PDE5i arm
Description: Patients will be treated by tadalafil 5 mg tablet daily in addition to four Tadalafil 5 mg tablet 3 hours before intercourse on demand in addition to placebo injection. Each injection session will consist of a total of 10 mL saline solution infused slowly over a 2-minute period; 5 mL each injected to the right and left corpus cavernosum.
Study: NCT05218655

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vatiquinone
Description: Vatiquinone will be administered per dose and schedule specified in the arm description.
Study: NCT06330441

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endoscopic ultrasonography
Description: endoscopic ultrasonography - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endoscopic ultrasonography
Description: endoscopic ultrasonography - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endoscopic ultrasonography
Description: endoscopic ultrasonography - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endoscopic ultrasonography
Description: endoscopic ultrasonography - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance
Description: magnetic resonance - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance
Description: magnetic resonance - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance
Description: magnetic resonance - frequency defined by arm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance
Description: magnetic resonance - frequency defined by arm

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: laboratory examination
Description: hematology, biochemistry, Na+, K+, Cl-, Ca2+, bilirubin, ALT, AST, GGT, ALP, lactate dehydrogenase, creatinine, urea, fasting glycemia, HbA1c, alpha-amylase, LPS, albumin, total protein, CA19-9, CEA

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: laboratory examination
Description: hematology, biochemistry, Na+, K+, Cl-, Ca2+, bilirubin, ALT, AST, GGT, ALP, lactate dehydrogenase, creatinine, urea, fasting glycemia, HbA1c, alpha-amylase, LPS, albumin, total protein, CA19-9, CEA

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: laboratory examination
Description: hematology, biochemistry, Na+, K+, Cl-, Ca2+, bilirubin, ALT, AST, GGT, ALP, lactate dehydrogenase, creatinine, urea, fasting glycemia, HbA1c, alpha-amylase, LPS, albumin, total protein, CA19-9, CEA

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: laboratory examination
Description: hematology, biochemistry, Na+, K+, Cl-, Ca2+, bilirubin, ALT, AST, GGT, ALP, lactate dehydrogenase, creatinine, urea, fasting glycemia, HbA1c, alpha-amylase, LPS, albumin, total protein, CA19-9, CEA
Study: NCT06266221

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone 20 Mg
Description: Oral corticosteriods

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Placebo
Description: Oral placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 120 Mg
Description: IV corticosteriods

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IV Placebo
Description: IV placebo
Study: NCT05091034

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Controlling Asthma Program for Adolescents (CAMP Air)
Description: Controlling Asthma Program for Adolescents (CAMP Air) is an e-health intervention grounded in social cognitive theory and motivational interviewing to guide teens through asthma self-care and how to navigate the health care system. It makes use of various interactive and personalized approaches.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control Asthma Education Intervention
Description: Using Asthma Plus, an asthma education program, teens learn about asthma and other conditions relevant to asthma and adolescents.
Study: NCT06178666

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: Three dose levels of intradermal BCG

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: Three dose levels of intradermal BCG

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG
Description: Three dose levels of intradermal BCG
Study: NCT05036629

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Protocol
Description: Eye-tracker Eyelink (eye movements) BIOPAC : (electrodermal resistance) INVIVO Precess : breathing, arterial pressure, pulse,~* NIRS Oxymon artinis medical system~* tES (transcranial electrical stimulation, Neuroelectrics)
Study: NCT05106868

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Acupuncture is a form of alternative medicine and a component of traditional Chinese medicine (TCM) in which thin needles are inserted into the acupoints on body to treat diseases.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: acupuncture
Description: Acupuncture is a form of alternative medicine and a component of traditional Chinese medicine (TCM) in which thin needles are inserted into the acupoints on body to treat diseases.
Study: NCT05052827

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rice Protein Isolate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 394 Carbs (g): 6.50 Protein (g): 86.70 Fat (g): 2.39 Total BCAA (g): 14.98 Total EAA (g): 30.62 Total AA (g): 86.11

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rice Protein Isolate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 394 Carbs (g): 6.50 Protein (g): 86.70 Fat (g): 2.39 Total BCAA (g): 14.98 Total EAA (g): 30.62 Total AA (g): 86.11

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Soy Protein Isolate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 377 Carbs (g): 2.12 Protein (g): 88.8 Fat (g): 0.60 Total BCAA (g): 13.88 Total EAA (g): 31.74 Total AA (g): 89.39

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Soy Protein Isolate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 377 Carbs (g): 2.12 Protein (g): 88.8 Fat (g): 0.60 Total BCAA (g): 13.88 Total EAA (g): 31.74 Total AA (g): 89.39
Study: NCT06572358

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MetProUltima
Description: Test product Name: MetProUltima Marketed By\| Manufactured By: Meteoric Biopharmaceuticals Private Limited Mode of Usage: Take one capsule after each meal, twice daily. Frequency: Twice a Day Route of Administration: Oral
Study: NCT05360095

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meaning of Screening
Description: The Meaning of Screening game is a decision making tool that is accessible through the most common web platforms. Users have the ability to explore learn about prenatal screening through multiple approaches, including presentation of facts, personal stories, and values clarification. Users will access the game from their personal phone or computer prior to completing prenatal screening.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Genetic Counseling
Description: This intervention consists of a 45-minute prenatal screening genetic counseling session (in person or online) completed after confirmation of pregnancy and before actual screening.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Participants in the Usual Care group will receive the brochure-based education about prenatal screening that is currently recommended by American College of Obstetrics and Gynecology (ACOG), delivered in an electronic format so they can read it before they complete prenatal screening.
Study: NCT05052827

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Soy Protein Isolate
Description: Protein provided at 0.35 g/kg fat free-mass. Macronutrient and Amino Acid Content provided below.~Per 100 g protein powder:~Calories (Cal): 377 Carbs (g): 2.12 Protein (g): 88.8 Fat (g): 0.60 Total BCAA (g): 13.88 Total EAA (g): 31.74 Total AA (g): 89.39
Study: NCT04978194

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: University-based intervention to promote better management of emotions and learning
Description: It included 9 video capsules (that take place over 9 weeks), with the following themes: stress information, learning information, emotion and stress regulation strategies, cognitive and metacognitive learning strategies, motivation for learning, physical activity, diet, sleep, and managing worry and uncertainty. It is based on previous online student mental health intervention studies. It presents two innovative aspects: elements and examples specific to the COVID-19 pandemic and the addition of modules focused on learning strategies. The different modules were designed by 5 associate professors, 2 Master students in clinical psychology and 2 undergraduate students in psychology. For the control group, the videos will be posted every week on a You Tube channel and broadcast on a private discord group. For the hybrid group, student will have to attend 10 lessons of 2 hours. These courses include the viewing of videos and a time for discussion between students and the teacher.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: University-based intervention to promote better management of emotions and learning
Description: It included 9 video capsules (that take place over 9 weeks), with the following themes: stress information, learning information, emotion and stress regulation strategies, cognitive and metacognitive learning strategies, motivation for learning, physical activity, diet, sleep, and managing worry and uncertainty. It is based on previous online student mental health intervention studies. It presents two innovative aspects: elements and examples specific to the COVID-19 pandemic and the addition of modules focused on learning strategies. The different modules were designed by 5 associate professors, 2 Master students in clinical psychology and 2 undergraduate students in psychology. For the control group, the videos will be posted every week on a You Tube channel and broadcast on a private discord group. For the hybrid group, student will have to attend 10 lessons of 2 hours. These courses include the viewing of videos and a time for discussion between students and the teacher.
Study: NCT05615311

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Description: Study participants assigned to the intervention group will receive 800 IU/ day of vitamin D plus 200-300 IU/day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No additional vitamin D supplementation
Description: Study participants assigned to the control group will receive 200-300 IU/ day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.